World Health Organization calls for ALL flavored vapes to be banned
World Health Organization calls for ALL flavored vapes to be banned worldwide and ‘treated like cigarettes’ World Health Organization has […]
A new study carried out by researchers at Concordia’s School of Health provides a new way of looking at the […] People who are very sleepy during the day, despite a good night’s rest, may have a sleep disorder called idiopathic […] The overall risk for breast cancer (BC) is increased for women diagnosed with benign breast disease (BBD) in the percutaneous […] In a study of historic scale, scientists at Gladstone Institutes have created an intricate map of how the immune system […] insights from industryNicola TernettePrincipal Investigator Antigen DiscoveryUniversity of Oxford In this omg OMx podcast episode, Bruker's Kate Stumpo gets inside […] In a recent study published in the journal JAMA Network Open, researchers evaluated the clinical characteristics and patterns of post-COVID-19 […] Woman who has one in 7bn genes that make her ‘IMMUNE to Alzheimer’s’ may offer clues to beat disease The […] Patients with rare diseases have traditionally been the subjects of medical research. However, in recent years, their role has begun […] SOLASCURE Ltd (SolasCure), a biotechnology company developing a hydrogel containing tarumase (provisional INN), a recombinant enzyme derived from maggots, and […]Health News
A spinal muscles size and shape is linked to body fat, according to new research
Rare sleep disorder more prevalent than previously thought
Benign breast disease linked to increased risk for breast cancer
Using next-gen CRISPR tool, scientists create unprecedented molecular map of human immune response
Immunopeptidomics offer new hope in cancer research
U.S. veterans' study reveals key insights into Long COVID and protective role of vaccination
Woman who dodged Alzheimer's could hold clues to how to prevent it
Online space created for knowledge sharing of rare-disease research
SolasCure demonstrates proof-of-concept in Phase lla safety trial of Aurase Wound Gel